Results 71 to 80 of about 11,374 (196)

Case report of transient polymyalgia rheumatica after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine

SAGE Open Medical Case Reports
Messenger ribonucleic acid-based vaccines that target severe acute respiratory syndrome coronavirus 2 have shown high effectiveness. While these Coronavirus Disease 2019 vaccines have a favorable safety profile, there can be rare adverse drug reactions ...
Kosuke Matsuzono, Shigeru Fujimoto
doaj   +1 more source

Features of early diagnosis and treatment of polymyalgia rheumatic (PMR)

Российский журнал гериатрической медицины
RELAVANCE. Early diagnosis of PMR is important, since the duration of treatment and the outcome of the disease depend on it. W. Bruce, 1888 called PMR "prussic rheumatic gout" and only Barber, 1957 ― polymyalgia rheumatica.
V. T. Komarov, O. G. Grigoryeva, S. S. Fadeeva, N. S. Khichina   +3 more
doaj   +1 more source

Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang, Siwen Wu, Yusi Wang, Die Hu, Li Yang   +4 more
wiley   +1 more source

Risk of vascular events in patients with polymyalgia rheumatica.

, 2014
BACKGROUND: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of vascular disease.
Mallen, Christian D., Roddy, Edward, Hancock, Adam T., Hider, Samantha L., Muller, Sara, Belcher, John, Helliwell, Toby   +6 more
core   +1 more source

Clinical Features, Treatment and Monitoring in Patients With Polymyalgia Rheumatica

The Turkish Journal of Gastroenterology, 2015
Objectives: This study aims to evaluate the clinical symptoms and laboratory findings of Turkish patients with polymyalgia rheumatica. Patients and methods: Clinical data of 41 patients (9 males, 32 females; mean age 65.5±7.6 years; range 60 to 80 ...
Fatma Gül YURDAKUL, Hatice BODUR, Filiz SİVAS, Bedriye BAŞKAN, Filiz ESER, Onur YILMAZ   +5 more
doaj  

A Twist in the Tale: The Unmasking of Listeria in a PMR Case

Clinical Case Reports
In general, an older patient presenting with proximal muscle pain and fatigue, with elevated inflammatory markers, would generally result in an extensive evaluation.
Ghassan Al‐Qaysi, Viswaja Kaja, Rishitha Anumola, Adegbenga Bankole   +3 more
doaj   +1 more source

Vitamin D: Physiology, Pharmacology and Clinical Evidence for Supplementation—A Narrative Review

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 5, November 2026.
ABSTRACT Vitamin D is a nutrient and prohormone obtained from diet and supplements and synthesized in the skin. It is essential for calcium and phosphate homeostasis and skeletal health and influences multiple extra‐skeletal processes, yet deficiency remains common worldwide.
Jyrki K. Virtanen
wiley   +1 more source

Exercise‐induced vasculitis with histological and genetic evidence of complement involvement

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Massimo Cugno, Paolo Calzari, Alessandra Di Benedetto, Francesca Laura Boggio, Chiara Moltrasio, Luigi Porcaro, Angelo Valerio Marzano   +6 more
wiley   +1 more source

Pulse steroid treatment of polymyalgia rheumatica

, 2004
Pulse steroid treatment of polymyalgia ...
Pulsatelli, L, Macchioni, P, Cantini, F, Cimmino, M. A, SALVARANI, CARLO, Boiardi, L   +5 more
core  

Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls

, 2006
Objective: To explore the hypothalamic-pituitary-adrenal ( HPA) axis in polymyalgia rheumatica ( PMR)
OZOGUL, N., KELESTIMUR, F., CALIS, Mustafa, DURAK, A. C., KIRNAP, Mehmet, Demir, Hüseyin, TANRIVERDI, Fatih   +6 more
core   +1 more source